Publications

Luis María Máiz Carro publications

161 results

2026

  1. Biochemical characteristics of inhaled antibiotics related to tolerability

    Farmacia Hospitalaria, Vol. 50, Núm. 2, pp. 87-96

  2. Factors Associated With Long-Term Mortality in Bronchiectasis

    Archivos de Bronconeumologia

  3. Functional and Compositional Shifts in Lung and Gut Microbiota after One Year of Treatment with Highly Effective CFTR Modulators in Cystic Fibrosis

    Archivos de Bronconeumologia

  4. Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 30, Núm. 1, pp. 40-42

2025

  1. Aspergillus Pneumonia in an Immunocompetent Patient

    Open Respiratory Archives, Vol. 7, Núm. 2

  2. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 6, pp. 309-316

  3. Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids

    Open Respiratory Archives, Vol. 7, Núm. 2

  4. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

    Archivos de Bronconeumologia, Vol. 61, Núm. 4, pp. 196-202

  5. Exploring the complexities of intestinal and pulmonary microbiota in cystic fibrosis: A multi-omics approach

    Respiratory Medicine, Vol. 248

  6. Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis

    Archivos de Bronconeumologia, Vol. 61, Núm. 8, pp. 484-489

  7. Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis

    Open Respiratory Archives, Vol. 7, Núm. 3

  8. The impact of interstitial lung disease in patients with acid sphingomyelinase deficiency (ASMD) - A case series

    Respiratory Medicine Case Reports, Vol. 55

  9. Use of inhaled corticosteroids in bronchiectasis: Data from the European Bronchiectasis Registry (EMBARC)

    Thorax, Vol. 80, Núm. 6, pp. 358-368

  10. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?—data from the RIBRON registry

    Journal of Thoracic Disease, Vol. 17, Núm. 10, pp. 9003-9012

2024

  1. Aerosolized Ampicillin in a Patient With Recurrent Respiratory Infections

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 604-605

  2. Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

    The European respiratory journal, Vol. 63, Núm. 6

  3. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 6, pp. 1553-1562

  4. Evaluation of Insulin Secretion and Continuous Glucose Monitoring in Patients with Cystic Fibrosis After Initiation of Transmembrane Conductance Regulator Modulator: A 52-Week Prospective Study

    Diabetology, Vol. 5, Núm. 6, pp. 554-565

  5. From ivacaftor to gene therapy, what has changed in cystic fibrosis?

    Revista de Patologia Respiratoria, Vol. 27, Núm. 4, pp. 138-148

  6. Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 5